Episode Details

Bristol Myers Squibbs Opdivo gains expanded approvals for blood cancers, driving stock surge; AI partnership with Takeda and Astex adds to positive outlook.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/8159177d1e62271a